U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Enforcement Activities | FDA
  5. Unapproved Drugs
  6. FDA notification regarding cocaine hydrochloride solution products
  1. Unapproved Drugs

FDA notification regarding cocaine hydrochloride solution products

FDA requested companies stop distributing unapproved versions of cocaine hydrochloride solution.

The agency approved Genus Lifesciences Inc.’s Goprelto (cocaine hydrochloride) nasal solution (NDC 64950-0359) on December 14, 2017. All other cocaine hydrochloride products are unapproved new drugs that cannot be distributed in interstate commerce without a new drug application approved by FDA, including:

Drug NDC

Drug name

0527-1728-74

4% Cocaine Hydrochloride Topical Solution 4mL

0527-1728-73

4% Cocaine Hydrochloride Topical Solution 10mL

0527-1729-74

10% Cocaine Hydrochloride Topical Solution 4mL

0527-1729-73

10% Cocaine Hydrochloride Topical Solution 10mL

FDA encourages all drug companies of unapproved drugs to seek FDA approval. The NDC Directory identifies FDA approval status of all prescription drug marketed in the United States.

Back to Top